ArticleJACC. Advances2025
Association Between Congenital Heart Disease Complexity, Mental Health Conditions and Opioid Use Disorder.
Article in JACC. Advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAs patients with congenital heart disease (CHD) survive into adulthood, there is concern that more complex diagnoses, with possible repeat perioperative opioid exposures, may be associated with increased risk of opioid-related harms, including development of an opioid use disorder (OUD).
objectivesThe purpose of this study was to determine if OUD prevalence is higher among patients with more surgically complex CHD diagnoses.
methodsWe conducted a national retrospective cohort study among CHD patients aged 15 to 64 years between 2012 and 2022. Using clinical consensus, diagnoses were categorized as simple biventricular, complex biventricular, and single ventricle physiology conditions. Our primary outcome was OUD prevalence. Secondary outcomes included history of overdose, substance use disorders (SUD), and mental health diagnoses. Outcomes were captured in medical claims using International Classification of Diseases (Ninth Revision and Tenth Revision) diagnosis codes. We utilized multivariable logistic regression models to assess the association between CHD complexity, patient characteristics, and outcomes.
resultsAmong 73,046 CHD patients, the median age was 43.0 (Q1-Q3: 29.0-56.0) years, and 39,795 (54.5%) were female. OUD prevalence was 3.6% (n = 1,994 of 55,335) among simple biventricular patients, 1.9% (n = 269 of 14,077) among complex biventricular patients, and 3.5% (n = 126 of 3,634) among single ventricle physiology patients. Trends in overdose and SUD prevalence were similar. Simple biventricular and single ventricle patients had increased anxiety and mood disorder prevalence.
conclusionsPatients with more complex diagnoses had the lowest OUD/SUD prevalence. Comorbid mood and anxiety disorders were strongly associated with these outcomes. Findings support the need for additional research and routine mental health and OUD/SUD screening for CHD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.